CCN2 and pulmonary fibrosis: Studies of VC-associated hepatic, renal, and pulmonary fibrosis demonstrate upregulation of plasminogen activator inhibitor-1, transforming growth factor-β, platelet-derived growth factor, vascular endothelial growth factor, and connective tissue growth factor [35-37].